Drum Hill Capital’s Pfizer PFE Stock Holding History

Drum Hill Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,147	Closed	-$228K	–	48
2025 Q4	$228K	Hold	9,147	–	–	0.24%	45
2025 Q3	$233K	Hold	9,147	–	–	0.25%	43
2025 Q2	$222K	Hold	9,147	–	–	0.25%	43
2025 Q1	$232K	Hold	9,147	–	–	0.27%	42
2024 Q4	$243K	Buy	+9,147	New	+$248K	0.3%	40

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Drum Hill Capital's PFE Position: Q1 2026 in Review

Drum Hill Capital sold out of Pfizer (PFE) in Q1 2026, closing a stake of 9,147 shares — an estimated $228K sold.

Drum Hill Capital first reported a position in PFE in Q4 2024 and held it in 5 quarters. The position peaked at $243K in Q4 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Drum Hill Capital reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Drum Hill Capital sold 9,147 Pfizer shares in Q1 2026, an estimated $228K.
Drum Hill Capital first reported a position in Pfizer in Q4 2024 and held it in 5 quarters.
Drum Hill Capital's Pfizer position peaked at $243K in Q4 2024.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Drum Hill Capital's 13F filing for Q1 2026, filed 21 Apr 2026.